Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Minor formatting updates and small text edits are present, with no changes to core study details (title, NCT number, eligibility criteria, outcomes, or current status). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-10-27T21:06:27.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T08:25:54.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T04:56:48.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now declares Revision: v3.0.2, replacing the previous v3.0.1, indicating a maintenance release. The 'Back to Top' link was removed, a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-14T22:09:57.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T19:16:11.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations related to cancer treatment, while removing several specific terms and references to previous content, particularly in the area of cancer types and drug classifications.
    Difference
    3%
    Check dated 2025-08-31T12:29:28.000Z thumbnail image

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.